Crossmark

Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome

Crossref DOI link: https://doi.org/10.1186/s12967-022-03448-x

Published Online: 2022-05-26

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Hui-Hui

Guo, Yuan-Lin

Zhu, Cheng-Gang

Wu, Na-Qiong

Gao, Ying

Xu, Rui-Xia

Dong, Qian

Qian, Jie

Dou, Ke-Fei

Li, Jian-Jun http://orcid.org/0000-0003-2536-4364
Funding

Funding for this research was provided by:

the Capital Health Development Fund (201614035)

CAMS Major Collaborative Innovation Project (2016-I2M-1-011)
License Information

Text and Data Mining valid from 2022-05-26

Version of Record valid from 2022-05-26
More Information

Article History

Received: 6 March 2022

Accepted: 18 May 2022

First Online: 26 May 2022

Declarations

:

: This study was approved by the hospital’s ethical review board (Fu Wai Hospital & National Center for Cardiovascular Diseases, Beijing, China). Each participant provided written, informed consent before enrollment.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below